Search Results - "Rimsky, L"
-
1
-
2
Week 96 analysis of rilpivirine or efavirenz in HIV‐1‐infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double‐blind trials
Published in HIV medicine (01-01-2014)“…Objectives These 96‐week, ECHO/THRIVE pooled analyses evaluated data for antiretroviral treatment‐naïve, HIV‐1‐infected adults with viral load (VL) ≤ 100 000…”
Get full text
Journal Article -
3
White matter abnormalities in schizophrenia and schizotypal personality disorder
Published in Schizophrenia bulletin (01-01-2015)“…Prior diffusion tensor imaging (DTI) studies examining schizotypal personality disorder (SPD) and schizophrenia, separately have shown that compared with…”
Get full text
Journal Article -
4
Effect of a Combination of Clevudine and Emtricitabine with Adenovirus-Mediated Delivery of Gamma Interferon in the Woodchuck Model of Hepatitis B Virus Infection
Published in Antimicrobial Agents and Chemotherapy (01-07-2004)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
5
Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements
Published in Genes & development (01-10-1989)“…The Rex proteins of types I and II human T-cell leukemia viruses (HTLV-I, HTLV-II) are required for expression of the viral structural gene products, gag and…”
Get full text
Journal Article -
6
Cloning and expression of a cDNA for human thioredoxin
Published in The Journal of biological chemistry (25-10-1988)“…Thioredoxin is the best representative enzyme of a group of proteins, widely distributed and possessing dithiol-disulfide oxidoreductase activity. We have…”
Get full text
Journal Article -
7
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1
Published in Journal of Virology (01-10-1995)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
8
Epstein--Barr Virus-Containing B-Cell Line Produces an Interleukin 1 that It Uses as a Growth Factor
Published in Proceedings of the National Academy of Sciences - PNAS (01-02-1987)“…We report the establishment of a spontaneous interleukin 1 (IL-1)-producing subclone derived from the human Epstein--Barr virus (EBV)-containing…”
Get full text
Journal Article -
9
Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial
Published in AIDS (London) (02-01-2010)“…TMC278 is a next-generation nonnucleoside reverse transcriptase inhibitor highly active against wild-type and nonnucleoside reverse transcriptase…”
Get full text
Journal Article -
10
Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins
Published in Journal of Virology (01-04-1989)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
11
Rex transregulation of human T-cell leukemia virus type II gene expression
Published in Journal of Virology (01-01-1991)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
12
Rilpivirine vs. efavirenz in HIV-1 patients with baseline viral load 100 000 copies/ml or less: week 48 phase III analysis
Published in AIDS (London) (27-03-2013)“…To compare efficacy, resistance development, and safety between rilpivirine and efavirenz in treatment-naive, HIV-1-infected adults with baseline viral load…”
Get full text
Journal Article -
13
Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial
Published in AIDS research and human retroviruses (01-05-2012)“…TMC278-C204 (NCT00110305), a 96-week trial of the nonnucleoside reverse transcription inhibitor (NNRTI) rilpivirine (RPV, TMC278) in 368 HIV-1-infected,…”
Get more information
Journal Article -
14
Purification to homogeneity and NH2-terminal amino acid sequence of a novel interleukin 1 species derived from a human B cell line
Published in The Journal of immunology (1950) (01-05-1986)“…A subclone, referred to as 3B6, derived from a DR-negative EBV-transformed B cell line, has been found to spontaneously produce IL 1. 3B6-IL 1 displays a pI of…”
Get full text
Journal Article -
15
Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors
Published in Antiviral therapy (2009)“…Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are an important component of antiretroviral therapy for HIV type-1 (HIV-1)-infected patients…”
Get full text
Journal Article -
16
Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load less than or equal to 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials
Published in HIV medicine (01-01-2014)“…These 96-week, ECHO/THRIVE pooled analyses evaluated data for antiretroviral treatment-naive, HIV-1-infected adults with viral load (VL) less than or equal to…”
Get full text
Journal Article -
17
Week 96 efficacy and safety of rilpivirine in reatment-naive, HIV-1 patients in two Phase III randomized trials
Published in AIDS (London) (01-01-2013)“…Background: In the week 48 primary analysis of ECHO and THRIVE, rilpivirine demonstrated noninferior efficacy and more favourable tolerability versus efavirenz…”
Get full text
Journal Article -
18
Flow cytometry resonance energy transfer suggests an association between low-affinity interleukin 2 binding sites and HLA class I molecules
Published in Biochemical journal (15-05-1990)“…Using flow cytometry energy transfer we have studied the sterical proximity of interleukin 2 receptors and the heavy chain of the major histocompatibility…”
Get full text
Journal Article -
19
A novel protein from cloned human B-cell line displays IL-1 bioactivity
Published in The Journal of immunology (1950) (15-10-1988)Get full text
Journal Article -
20
Rilpivirine efficacy, virology and safety in ARV treatment‐naïve patients with viral load≤100,000 HIV‐1 RNA c/mL: ECHO and THRIVE 96‐week results
Published in Journal of the International AIDS Society (01-11-2012)“…Background In the ECHO and THRIVE Phase III, randomised, double‐blind trials, rilpivirine (RPV, TMC278, EDURANT) 25 mg qd showed non‐inferiority compared to…”
Get full text
Journal Article